New Perspectives in Glioblastoma: Nanoparticles-based Approaches

Curr Cancer Drug Targets. 2017;17(3):203-220. doi: 10.2174/1568009616666160813190732.

Abstract

Glioblastoma multiforme represents one of the most aggressive tumor of central nervous system. Current therapy includes surgery, radiation and chemotherapy. These treatments are rarely curative and glioma are associated with a poor prognosis. Nanomedicine represents the most innovative branch of medicine since many studies demonstrated great advantage in the diagnosis and therapy of several diseases. In this review we will summarize the results obtained by the use of nanoparticles and extracellular vesicles in glioblastoma. A great interest is raising from these studies that underlined the efficacy and specificity of this treatment for glioma, reducing side-effects associated with conventional therapies.

Keywords: Glioblastoma; extracellular vesicles; nanomedicine; nanoparticles.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / therapy*
  • Drug Delivery Systems / methods*
  • Genetic Therapy / methods
  • Glioblastoma / therapy*
  • Humans
  • Immunotherapy / methods
  • Liposomes / administration & dosage
  • Liposomes / chemistry
  • Molecular Targeted Therapy / methods
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry
  • Nanoparticles / therapeutic use*
  • Nanoshells / chemistry
  • Nanoshells / therapeutic use
  • Quantum Dots

Substances

  • Antineoplastic Agents
  • Liposomes